Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Validation of an Algorithm for Predicting Awakenings Associated With Trauma-related Nightmares, Based on the Analysis of Physiological Patterns in Military and Former Military Patients Suffering From Post-traumatic Stress Disorder (CAUD-PIN)

28. September 2026 aktualisiert von: Direction Centrale du Service de Santé des Armées

The goal of this clinical trial is to validate an artificial intelligence algorithm called CAUD-PIN (CAUchemar Detection on INdividualized Parameters) to predict nightmare-related awakenings in military personnel and veterans suffering from post-traumatic stress disorder (PTSD). The main question it aim to answer is :

  • Can the CAUD-PIN algorithm detect physiological patterns preceding trauma-related nightmare awakenings with a sensitivity greater than 80%?
  • What physiological signals best predict the occurrence of a trauma-related nightmare awakening?

Participants will:

Wear two non-invasive devices at home - an EEG headband and a wrist-worn sensor bracelet - for 15 consecutive nights Press a button on the bracelet each time they wake up from a nightmare Complete sleep and daytime diaries every evening and morning Attend two clinical assessments (at enrollment and at the end of the study, one month later) at one of the three participating military hospitals

The algorithm will be applied to the recorded data after collection and does not intervene in real time or affect participants' standard medical care in any way.

Studienübersicht

Status

Rekrutierung

Bedingungen

Intervention / Behandlung

Studientyp

Interventionell

Einschreibung (Geschätzt)

27

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studieren Sie die Kontaktsicherung

Studienorte

      • Brest, Frankreich, 29200
        • Rekrutierung
        • Clermont Tonnerre Regional Military Teaching Hospital, psychiatry department
        • Kontakt:
          • Julia SALOMÉ, MD, PHD
      • Clamart, Frankreich, 92190
        • Noch keine Rekrutierung
        • Percy National Military Teaching Hospital, Department of Psychiatry
        • Kontakt:
          • Gilles SIPAHIMALANI, MD, PhD
    • Île-de-France Region
      • Saint-Mandé, Île-de-France Region, Frankreich, 94160

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 65 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Age between 18 and 65 years (age limit related to military status)
  • Active military personnel or veterans
  • Receiving psychiatric care in a military hospital (HNIA Bégin, HNIA Percy, or HRIA Brest) for PTSD related to combat trauma (exposure to death or life-threatening situations)
  • PCL-5 score > 33
  • Written informed consent obtained
  • Trauma-related nightmares occurring ≥ 4 times per week

Exclusion Criteria:

  • Pre-existing progressive psychiatric disorder prior to trauma (condition requiring long-term treatment > 1 year)
  • Sleep disorder affecting sleep architecture (obstructive sleep apnea syndrome, narcolepsy)
  • Neurological disorder (acute confusional state, severe traumatic brain injury) Inability to provide informed consent
  • Persons under legal protection measures (guardianship, curatorship, or equivalent judicial protection)
  • Persons not affiliated with a social security scheme

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Grundlegende Wissenschaft
  • Zuteilung: N / A
  • Interventionsmodell: Einzelgruppenzuweisung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: CAUD-PIN Validation Group

French Military personnel and/or veterans with PTSD wear two non-invasive wearable devices at home - an EEG headband (Hypnodyne Zmax Lite) and a multisensor bracelet (Empatica EmbracePlus) - for 15 consecutive nights. Participants press a button on the bracelet to report each nightmare-related awakening. Physiological data are analyzed post-hoc by the CAUD-PIN algorithm to validate its ability to predict trauma-related nightmare awakenings. Two clinical assessments are conducted at enrollment and at study completion.

CAUD-PIN (CAUchemar Detection on INdividualized Parameters) is a non-invasive, AI-based predictive algorithm developed by the VIFASOM research team (UMR 7330, Université Paris Cité / French Military Health Service) from the SOMMEPT clinical project. It analyzes multimodal physiological signals recorded during home sleep to identify patterns preceding Trauma-related nightmare awakenings in military patients with PTSD. Data are collected using two wearable devices: an EEG headband (Hypnodyne Zmax Lite) measuring brain activity and sleep stages, and a wrist-worn multisensor bracelet (Empatica EmbracePlus) measuring heart rate, electrodermal activity, skin temperature, and motor activity. The algorithm is applied exclusively post-hoc to pseudonymized recordings, with no real-time intervention and no impact on participants' standard medical care.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Sensitivity of the CAUD-PIN algorithm in predicting Trauma-related nightmare awakenings
Zeitfenster: During the 15 consecutive nights of home sleep recording

Sensitivity will be calculated as the number of Trauma-related nightmare awakenings correctly identified by the CAUD-PIN algorithm divided by the total number of confirmed trauma-related nightmare awakenings, multiplied by 100.

Unit of Measure: Percentage

During the 15 consecutive nights of home sleep recording

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Specificity of the CAUD-PIN algorithm for predicting Trauma-related nightmare awakenings
Zeitfenster: During the 15 consecutive nights of home sleep recording

Specificity will be calculated as the number of events correctly classified as not being trauma-related nightmare awakenings divided by the total number of confirmed non-nightmare events, multiplied by 100.

Unit of Measure: Percentage

During the 15 consecutive nights of home sleep recording
Positive predictive value of the CAUD-PIN algorithm
Zeitfenster: During the 15 consecutive nights of home sleep recording

Positive predictive value will be calculated as the number of correctly predicted trauma-related nightmare awakenings divided by the total number of trauma-related nightmare awakenings predicted by the CAUD-PIN algorithm, multiplied by 100.

Unit of Measure: Percentage

During the 15 consecutive nights of home sleep recording
Negative predictive value of the CAUD-PIN algorithm
Zeitfenster: During the 15 consecutive nights of home sleep recording

Negative predictive value will be calculated as the number of events correctly predicted as not being trauma-related nightmare awakenings divided by the total number of events predicted as not being trauma-related nightmare awakenings, multiplied by 100.

Unit of Measure: Percentage

During the 15 consecutive nights of home sleep recording
Prediction lead time before trauma-related nightmare awakening
Zeitfenster: Through 15 nights of recording

Mean time (in seconds) between the physiological predictive pattern detected by the CAUD-PIN algorithm and the participant's button press indicating a trauma-related nightmare awakening.

Unit of Measure: Seconds

Through 15 nights of recording
Intra- and inter-individual variability in heart rate preceding trauma-related nightmare awakenings
Zeitfenster: During the 15 consecutive nights of home sleep recording

Intra- and inter-individual variability in heart rate (beats per minute, bpm) preceding trauma-related nightmare awakenings.

Variability will be quantified using:

  • Within-subject standard deviation (SD)
  • Between-subject variance estimated using mixed-effects models
During the 15 consecutive nights of home sleep recording
Intra- and inter-individual variability in electrodermal activity preceding trauma-related nightmare awakenings
Zeitfenster: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)

Intra- and inter-individual variability in electrodermal activity (microsiemens, µS) preceding trauma-related nightmare awakenings.

Variability will be quantified using:

  • Within-subject standard deviation (SD)
  • Between-subject variance estimated using mixed-effects models
After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)
Intra- and inter-individual variability in skin temperature preceding trauma-related nightmare awakenings
Zeitfenster: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)

Intra- and inter-individual variability in skin temperature (°C) preceding trauma-related nightmare awakenings.

Variability will be quantified using:

  • Within-subject standard deviation (SD)
  • Between-subject variance estimated using mixed-effects models
After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)
Intra- and inter-individual variability in motor activity preceding trauma-related nightmare awakenings
Zeitfenster: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)

Intra- and inter-individual variability in motor activity (activity counts) preceding trauma-related nightmare awakenings.

Variability will be quantified using:

  • Within-subject standard deviation (SD)
  • Between-subject variance estimated using mixed-effects models
After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)
Area Under the Curve (AUC) of the CAUD-PIN algorithm on combined dataset
Zeitfenster: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)

Area Under the Receiver Operating Characteristic Curve (AUC, unitless) of the CAUD-PIN algorithm when trained and evaluated on the CAUD-PIN dataset alone compared to the combined dataset (SOMMEPT + CAUD-PIN).

After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)
F1-score of the CAUD-PIN algorithm on combined dataset
Zeitfenster: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)

F1-score (unitless) of the CAUD-PIN algorithm when trained and evaluated on the CAUD-PIN dataset alone compared to the combined dataset (SOMMEPT + CAUD-PIN).

After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)
Correlation between PCL-5 total score and percentage of trauma-related nightmare nights
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

PTSD severity will be assessed at T1 using the PTSD Checklist for DSM-5 (PCL-5) total score, ranging from 0 to 80 points. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Beck Depression Inventory total score and percentage of trauma-related nightmare nights
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

Depression severity will be assessed at T1 using the Beck Depression Inventory (BDI) total score, ranging from 0 to 63 points. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between WHOQOL-BREF score and percentage of trauma-related nightmare nights
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

Quality of life will be assessed at T1 using the World Health Organization Quality of Life-BREF (WHOQOL-BREF) [specify total or domain score and range]. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Nightmare Severity Index score and percentage of trauma-related nightmare nights
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

Nightmare severity will be assessed at T1 using the Nightmare Severity Index (NSI) total score. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between mean number of trauma-related nightmare awakenings per night and percentage of trauma-related nightmare nights
Zeitfenster: During the 15 consecutive nights of home sleep recording

The mean number of trauma-related nightmare awakenings per night will be calculated as the total number of participant-confirmed trauma-related nightmare awakenings divided by the number of valid recording nights. The percentage of trauma-related nightmare nights will be calculated as the percentage of valid recording nights containing at least one confirmed awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

During the 15 consecutive nights of home sleep recording
Correlation between mean heart rate and percentage of trauma-related nightmare nights
Zeitfenster: During the 15 consecutive nights of home sleep recording

Heart rate will be measured in beats per minute using Empatica EmbracePLUS. For each participant, mean heart rate will be calculated across sleep period preceeding trauma-ralated awakeking across 15 nights. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

During the 15 consecutive nights of home sleep recording
Correlation between mean electrodermal activity and percentage of trauma-related nightmare nights
Zeitfenster: During the 15 consecutive nights of home sleep recording

Electrodermal activity will be measured in microsiemens (µS) using Empatica EmbracePLUS. For each participant, mean electrodermal activity will be calculated across across sleep period preceeding trauma-ralated awakeking across across sleep period preceeding trauma-ralated awakeking across 15 nights. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

During the 15 consecutive nights of home sleep recording
Correlation between mean skin temperature and percentage of trauma-related nightmare nights
Zeitfenster: During the 15 consecutive nights of home sleep recording

Skin temperature will be measured in degrees Celsius using Empatica EmbracePLUS. For each participant, mean skin temperature will be calculated across across sleep period preceeding trauma-ralated awakeking across 15 nights. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

During the 15 consecutive nights of home sleep recording
Correlation between mean motor activity and percentage of trauma-related nightmare nights
Zeitfenster: During the 15 consecutive nights of home sleep recording

Motor activity will be measured in activity counts using Empatica EmbracePLUS. For each participant, mean motor activity will be calculated across across sleep period preceeding trauma-ralated awakeking across 15 nights. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

During the 15 consecutive nights of home sleep recording
Correlation between trauma-related nightmare awakening frequency and change in PCL-5 total score between T1 and T2
Zeitfenster: From Visit 1 (baseline) to Visit 2 (end of study, Day 30 ± 5 days after inclusion)

Trauma-related nightmare frequency will be calculated as the total number of participant-confirmed trauma-related nightmare awakenings divided by the number of valid recording nights, expressed as awakenings per night. PTSD severity will be assessed at T1 and T2 using the PCL-5 total score, ranging from 0 to 80 points. Change will be calculated as the difference between the PCL-5 total scores obtained at T1 and T2. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

From Visit 1 (baseline) to Visit 2 (end of study, Day 30 ± 5 days after inclusion)
Correlation between trauma-related nightmare awakening frequency and change in Beck Depression Inventory total score between T1 and T2
Zeitfenster: From Visit 1 (baseline) to Visit 2 (end of study, Day 30 ± 5 days after inclusion)

Trauma-related nightmare frequency will be calculated as the total number of participant-confirmed trauma-related nightmare awakenings divided by the number of valid recording nights, expressed as awakenings per night. Depression severity will be assessed at T1 and T2 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Change will be calculated as the difference between the BDI total scores obtained at T1 and T2. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

From Visit 1 (baseline) to Visit 2 (end of study, Day 30 ± 5 days after inclusion)
Correlation between trauma-related nightmare awakening frequency and change in WHOQOL-BREF score between T1 and T2
Zeitfenster: From Visit 1 (baseline) to Visit 2 (end of study, Day 30 ± 5 days after inclusion)

Trauma-related nightmare frequency will be calculated as the total number of participant-confirmed trauma-related nightmare awakenings divided by the number of valid recording nights, expressed as awakenings per night. Quality of life will be assessed at T1 and T2 using the WHOQOL-BREF [specify total or domain score and range]. Change will be calculated as the difference between the WHOQOL-BREF scores obtained at T1 and T2. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

From Visit 1 (baseline) to Visit 2 (end of study, Day 30 ± 5 days after inclusion)
Correlation between PCL-5 total score at T1 and PSQI total score
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

PTSD severity will be assessed at T1 using the PCL-5 total score, ranging from 0 to 80 points. Subjective sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI) total score, ranging from 0 to 21 points, with higher scores indicating poorer sleep quality. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between PCL-5 total score at T1 and mean total sleep time
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

PTSD severity will be assessed at T1 using the PCL-5 total score, ranging from 0 to 80 points. Total sleep time will be measured in minutes usingHypnodyne Zmax Lite device and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between PCL-5 total score at T1 and mean sleep efficiency
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

PTSD severity will be assessed at T1 using the PCL-5 total score, ranging from 0 to 80 points. Sleep efficiency will be measured usingHypnodyne Zmax Lite device and PSQI questionnary, calculated as total sleep time divided by time in bed and multiplied by 100, and averaged across valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between PCL-5 total score at T1 and mean wake after sleep onset
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

PTSD severity will be assessed at T1 using the PCL-5 total score, ranging from 0 to 80 points. Wake after sleep onset will be measured in minutes using Hypnodyne Zmax Lite device and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Beck Depression Inventory total score at T1 and PSQI total score
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

Depression severity will be assessed at T1 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Subjective sleep quality will be assessed using the PSQI total score, ranging from 0 to 21 points, with higher scores indicating poorer sleep quality. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Beck Depression Inventory total score at T1 and mean total sleep time
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

Depression severity will be assessed at T1 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Total sleep time will be measured in minutes using Hypnodyne Zmax Lite device and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Beck Depression Inventory total score at T1 and mean sleep efficiency
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

Depression severity will be assessed at T1 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Sleep efficiency will be measured using Hypnodyne Zmax Lite device and PSQI questionnary, calculated as total sleep time divided by time in bed and multiplied by 100, and averaged across valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Beck Depression Inventory total score at T1 and mean wake after sleep onset
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

Depression severity will be assessed at T1 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Wake after sleep onset will be measured in minutes using using Hypnodyne Zmax Lite device and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Nightmare Severity Index score at T1 and PSQI total score
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

Nightmare severity will be assessed at T1 using the Nightmare Severity Index total score.. Subjective sleep quality will be assessed using the PSQI total score, ranging from 0 to 21 points, with higher scores indicating poorer sleep quality. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Nightmare Severity Index score at T1 and mean total sleep time
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

Nightmare severity will be assessed at T1 using the Nightmare Severity Index total score.. Total sleep time will be measured in minutes using Hypnodyne Zmax Lite and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Nightmare Severity Index score at T1 and mean sleep efficiency
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

Nightmare severity will be assessed at T1 using the Nightmare Severity Index total score.. Sleep efficiency will be measured using Hypnodyne Zmax Lite and PSQI questionnary, calculated as total sleep time divided by time in bed and multiplied by 100, and averaged across valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Nightmare Severity Index score at T1 and mean wake after sleep onset
Zeitfenster: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

Nightmare severity will be assessed at T1 using the Nightmare Severity Index total score.. Wake after sleep onset will be measured in minutes using Hypnodyne Zmax Lite and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Ermittler

  • Hauptermittler: Emeric SAGUIN, MD, PhD, Department of Psychiatry, Begin National Military Teaching Hospital, Saint-Mandé, 94160, France

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

30. April 2026

Primärer Abschluss (Geschätzt)

1. Oktober 2027

Studienabschluss (Geschätzt)

1. Oktober 2027

Studienanmeldedaten

Zuerst eingereicht

2. April 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

28. September 2026

Zuerst gepostet (Tatsächlich)

1. Oktober 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

1. Oktober 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

28. September 2026

Zuletzt verifiziert

1. März 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 2025PBMD01

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Individual participant data will not be shared. This study involves military personnel and veterans with PTSD, whose physiological and psychological data are considered highly sensitive. Data are pseudonymized and managed in accordance with the French General Data Protection Regulation (GDPR, EU 2016/679) and the Reference Methodology MR-001. Access is restricted to authorized members of the research team. Only aggregated and de-identified results will be disseminated through scientific publications and conference presentations.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .